Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies
- PMID: 10799460
- PMCID: PMC95893
- DOI: 10.1128/CDLI.7.3.451-456.2000
Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies
Abstract
Ten microbiological departments in Norway have participated in a multicenter evaluation of the following commercial tests for detection of Epstein-Barr virus (EBV)-specific and heterophile antibodies: CAPTIA Select viral capsid antigen (VCA)-M/G/EBNA (Centocor Inc.), Enzygnost anti-EBV/immunoglobulin M (IgM) and IgG (Dade Behring), Vironostika EBV VCA IgM/IgG/EBNA enzyme-linked immunosorbent assay (ELISA) (Organon Teknika), SEROFLUOR immunofluorescence assay and EBV Combi-Test (Institute Virion Ltd.), anti-EBV recombinant IgM- and IgG-early antigen/EBNA IgG ELISA (Biotest Diagnostics), EBV IgM/IgG/EBNA ELISA (Gull Laboratories), Paul-Bunnell-Davidsohn test (Sanofi Diagnostics Pasteur), Monosticon Dri-Dot (Organon Teknika), Avitex-IM (Omega Diagnostics Ltd.), Alexon Serascan infectious mononucleosis test (Alexon Biomedical Inc. ), Clearview IM (Unipath Ltd.), and Cards+/-OS Mono (Pacific Biotech, Inc.). The test panel included sera from patients with primary EBV infection, immunocompromised patients with recent cytomegalovirus infection, healthy persons (blood donors), and EBV-seronegative persons. Among the tests for EBV-specific antibodies the sensitivity was good, with only small differences between the different assays. However, there was a greater variation in specificity, which varied between 100% (Enzygnost) and 86% (Biotest). Tests for detection of heterophile antibodies based on purified or selected antigen (Avitex, Alexon, Clearview IM, and Cards+/-OS Mono) were more sensitive than the Paul-Bunnell-Davidsohn and Monosticon tests.
References
-
- Aalto S M, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol. 1998;56:186–191. - PubMed
-
- Elgh F, Linderholm M. Evaluation of six commercially available kits using purified heterophile antigen for the rapid diagnosis of infectious mononucleosis compared with Epstein-Barr virus-specific serology. Clin Diagn Virol. 1996;7:17–21. - PubMed
-
- Hofmann H, Popow-Kraupp T. Diagnosis of EBV infection by means of ELISA. Serodiagn Immunother Infect Dis. 1994;6:135–139.
-
- Høiby E A, Tjade T, Røtterud O J. Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. APMIS. 1985;93:145–151. - PubMed
-
- Hornef M W, Bein G, Fricke L, Steinhoff J, Wagner H-J, Hinderer W, Sonneborn H-H, Kirchner H. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation. 1995;60:474–480. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
